Hi @yannpiot
I continue to top up at these levels, but as I am not good at TA, I have no idea whether we are at the bottom of this cycle or not.
While RAC is a speculative share, IMO with each new announcement the risks of failure have been diminishing. Assuming the multiple upcoming pre-clinical & clinal trial results are also positive, then the risks will continue to diminish. Ofcourse, the real bonanza will come if Zantrene is shown to be highly effective in cancer patients. We all await that day with anticipation.
If Zantrene does prove to be effective in humans, then I think the price you pay for shares today will be largely irrelevant, as it will be the selling price of RAC to big pharma that will be the main determinate of your financial gains.
Hi @yannpiotI continue to top up at these levels, but as I am...
-
- There are more pages in this discussion • 10,115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |